Insight, Top 50 Pharma

Shire: Company Profile

Posted on 02 February 2012

Return to top 50 pharma list

Summary

Website: Shire

Headquarters: Dublin, Ireland

Ticker Symbol: SHP (London Stock Exchange) S7E (Frankfurt Stock Exchange)

SEC Link: Shire

Subsidiaries:

Atlantic Pharmaceutical Services

BioChem Pharma

Jerini

Movetis

New River Pharmaceuticals

Shire BioChem

Shire Human Genetic Therapies

Shire US Manufacturing

Supernus Pharmaceuticals

Transkaryotic Therapies

Top 50 Pharma ranking*: 37

*Ranking based on reported global pharma sales for year ending December 2010.

Sales revenue (USD billions) [% change from 2009]: $3.1 [16.1%]

R&D spend (USD millions): $662

Top-selling drugs (USD billions): Vyvanse [0.6]

Partnering activity

View partnering activity: 2011,2010,2009,2008,2007,2006,2005

Full details on each deal can be found at CurrentAgreements (subscription required)

M&A activity

View M&A activity: 2011,2010,2009,2008,2007,2006,2005

Full details on each deal can be found at CurrentAgreements (subscription required)

Available reports from Current Partnering:

Partnering Agreements with Shire

Partnering Agreements with Big Pharma, 3rd edition

Search all reports

Available resources providing deal coverage for Shire:

Current Agreements (subscription required)

Request a complimentary trial

Search Current Partnering for mention of Shire:

Search now

return to top 50 pharma list

Leave a Reply

*

bannerpng
biomarker-world-congress-2012jpg
molecular-diagnostics-june-2012jpg

Latest Tweets